People · Operator
Named in public records as an officer, director or promoter · active 2014–2016 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Leafline Labs, LLC | — | Pharmaceuticals | Series A | $27.5M | $4.6M | 2014 |
Glenn Taylor at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Glenn Taylor on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mitchell Baruchowitz | 1 | 8 |
| Ethan Ruby | 1 | 6 |
| Gary Starr | 1 | 4 |
| Colin Kelley | 1 | 4 |
| Mark Bachman | 1 | 3 |
| Andrew Bachman | 1 | 2 |
| Christopher Weidling | 1 | 2 |
| Emmanuel Munson-Regala | 1 | 1 |
| Peter Bachman | 1 | 1 |
| Paul Bachman | 1 | 1 |
| Kelly Henry | 1 | 1 |
| Tara Mulloy | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.